| 1 |
triple-negative breast cancer
(8648 times)
|
Neoplasms
(3860 times)
|
OS (640 times)
ER (441 times)
HER2 (409 times)
|
2008 Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
|
| 2 |
triple-negative BC
(131 times)
|
Neoplasms
(72 times)
|
BC (117 times)
OS (16 times)
HER2 (15 times)
|
2011 Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer.
|
| 3 |
triple receptor-negative breast cancer
(15 times)
|
Neoplasms
(10 times)
|
OS (3 times)
RFS (3 times)
ER (2 times)
|
2009 Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.
|
| 4 |
triple-negative subtype of breast cancer
(9 times)
|
Neoplasms
(3 times)
|
CAFs (1 time)
CAI (1 time)
CSC (1 time)
|
2016 TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
|
| 5 |
triple-negative (PR-, ER-, HER-2-) breast cancer
(4 times)
|
Medicine
(1 time)
|
ASMT (2 times)
PCTs (2 times)
TPBC (2 times)
|
2011 Vascular characterisation of triple negative breast carcinomas using dynamic MRI.
|
| 6 |
TNBC-TICs
(2 times)
|
Neoplasms
(1 time)
|
TPBC (2 times)
ER (1 time)
HER2 (1 time)
|
2012 A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease.
|
| 7 |
TNBCtype
(2 times)
|
Medicine
(1 time)
|
FF (1 time)
FFPE (1 time)
IM (1 time)
|
2016 Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
|
| 8 |
third cancer of non-breast origin
(1 time)
|
Neoplasms
(1 time)
|
BBC (1 time)
CI (1 time)
HR (1 time)
|
2012 Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer.
|
| 9 |
TN breast cancer
(1 time)
|
Veterinary Medicine
(1 time)
|
CK (1 time)
CMCs (1 time)
PR (1 time)
|
2021 Vitamin D receptor (VDR) expression in different molecular subtypes of canine mammary carcinoma.
|
| 10 |
TNBC MDA-MB-231 cell line and in vivo in an M-Wnt tumour-bearing
(1 time)
|
Chemistry
(1 time)
|
DOX (1 time)
PEG (1 time)
TAMs (1 time)
|
2023 Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations.
|
| 11 |
TNBC.Abbreviations:Triple-negative breast cancer
(1 time)
|
Drug Therapy
(1 time)
|
ADCs (1 time)
BCs (1 time)
BL1 (1 time)
|
2022 Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer.
|
| 12 |
TNBC/DDP
(1 time)
|
Neoplasms
(1 time)
|
USP22 (1 time)
|
2022 USP22 Contributes to Chemoresistance, Stemness, and EMT Phenotype of Triple-Negative Breast Cancer Cells by egulating the Warburg Effect via c-Myc Deubiquitination.
|
| 13 |
Trigeminal nerve balloon compression
(1 time)
|
Neurosurgery
(1 time)
|
---
|
2022 Trigeminal Neuralgia-Step-by-Step DYNA-Computed Tomography-Assisted Balloon Compression Rhizotomy.
|
| 14 |
Triple Negative BC form
(1 time)
|
Neoplasms
(1 time)
|
BC (1 time)
|
2021 Discovery and Pharmacological Evaluation of STEAP4 as a Novel Target for HER2 Overexpressing Breast Cancer.
|
| 15 |
triple negative group of human breast carcinoma
(1 time)
|
Neoplasms
(1 time)
|
AA (1 time)
WI (1 time)
|
2012 Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival.
|
| 16 |
Triple Negative subset of Breast Cancer
(1 time)
|
Medicine
(1 time)
|
RD (1 time)
WP (1 time)
|
2013 Differential activation of Wnt-beta-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner.
|
| 17 |
triple-negative (estrogen receptor, progesterone receptor, and HER-2/neu) breast cancer
(1 time)
|
Neoplasms
(1 time)
|
miRNAs (1 time)
|
2014 Identification of microRNA-93 as a functional dysregulated miRNA in triple-negative breast cancer.
|
| 18 |
triple-negative BC subtype
(1 time)
|
Cell Biology
(1 time)
|
BC (1 time)
BLBC (1 time)
EMT (1 time)
|
2021 Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments.
|
| 19 |
triple-negative breast carcinoma cell line MDA-MB-231
(1 time)
|
Cell Biology
(1 time)
|
TPBC (1 time)
|
2022 Triple-negative and triple-positive breast cancer cells reciprocally control their growth and migration via the S100A4 pathway.
|
| 20 |
triple-negative breast carcinomas of no special type
(1 time)
|
Cell Biology
(1 time)
|
HIF-1alpha (1 time)
LVD (1 time)
MVD (1 time)
|
2011 Angiogenesis in triple-negative adenoid cystic carcinomas of the breast.
|
| 21 |
triple-negative breast malignancies
(1 time)
|
Pathologic Processes
(1 time)
|
IBC (1 time)
|
2022 Revisiting Metaplastic Carcinoma of Breast: An Emphasis on the Clinico-pathological and Immunohistochemical Variables Analyzed at a Tertiary Cancer Centre in South India.
|
| 22 |
type breast cancer
(1 time)
|
Clinical Laboratory Techniques
(1 time)
|
---
|
2011 Establishment of a triple-negative type human breast cancer cell line that selectively metastasizes to the lung after orthotropic implantation.
|
A Search Service for Abbreviation / Long Form